Theranos Experience Exposes Weaknesses in FDA Regulatory Discretion. Academic Article uri icon

Overview

publication date

  • July 24, 2017

Research

keywords

  • Clinical Laboratory Techniques
  • Diagnostic Test Approval
  • United States Food and Drug Administration

Identity

Scopus Document Identifier

  • 85028773593

Digital Object Identifier (DOI)

  • 10.1002/cpdd.374

PubMed ID

  • 28741304

Additional Document Info

volume

  • 6

issue

  • 5